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Hepatic angiosarcoma: A sug-
gestive pattern of enhancement
on dynamic MR imaging
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Primary  hepatic  tumors  can  arise  from  different  compo-
nents  of  the  liver  such  as  hepatocytes,  bile  duct  epithelia,
neuroendocrine  cells,  and  mesenchymal  cells.  Despite  its
rarity,  hepatic  angiosarcoma  (HA)  is  the  most  common
malignant  mesenchymal  tumor  of  the  liver  [1].  HA  usually
develops  in  the  absence  on  an  underlying  or  pre-existing
liver  disease  and  its  pathogenesis  remains  unknown.  In
most  cases,  no  obvious  risk  factors  can  be  identiﬁed
[2].
Radiologically,  hepatic  angiosarcomas  may  have  vari-
able  appearances,  so  that  a  deﬁnitive  diagnosis  requires
histopathologic  examination  [3].  HA  may  present  as  differ-
ent  growth  patterns  such  as  multiples  nodules,  dominant
masses  or  rarely,  diffuse  inﬁltrating  micronodular  tumor
[2].  On  computed  tomography  (CT)  examination,  nodules
are  predominantly  hypoattenuating,  potentially  mixed  with
some  hypoattenuating  areas  caused  by  intratumoral  varia-
tions  like  fresh  or  hemorrhage  [4].
However,  studies  describing  the  morphologic  features  or
enhancement  pattern  of  HA  on  MRI  are  scarce.  We  report
herein  the  MRI  features  of  hepatic  angiosarcoma.
Case  report
A  sixty-two-year-old  Caucasian  woman  was  admitted  to
our  hospital  because  of  weight  loss,  fatigue  and  jaundice.
She  had  a  previous  history  of  strong  alcohol  intake  and
hepatitis  B  virus  infection.  Clinical  examination  showed
abdominal  distension  with  ascites,  collateral  venous  cir-
culation  and  stellar  angiomas  without  encephalopathy  or
focal  neurological  abnormalities.  The  laboratory  data  at
admission  included:  total  bilirubin,  63  mmol/dL  (normal:
3—18  mmol/dL);  albumin,  35  g/dL,  prothrombin  time,  65%.
The  serum  alpha  fetoprotein  level  was  normal.
Abdominal  ultrasonography  revealed  hepatomegaly  with
presence  of  multiple,  large  heterogeneous  nodules  within
both  lobes  of  the  liver.  MRI  examination  was  subsequently
performed  for  further  characterization  of  the  liver  lesions  on
a  1.5  Tesla  closed  magnet  system  (Achieva,  Philips  Medical
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2211-5684/© 2014 Éditions franc¸aises de radiologie. Published by Elsevieystems,  Best,  The  Netherlands)  with  a  dedicated  abdominal
hased  array  coil  for  signal  reception.
MR  images  demonstrated  a multifocal  macronodular  inﬁl-
ration  of  both  hepatic  lobes.  The  tumors  showed  low  signal
ntensity  on  T1-weighted  images  and  heterogeneous,  and
ecame  markedly  hyperintense  on  T2-weighted  MR  images.
ome  of  them,  particularly  those  with  small  diameter,
id  not  enhance  after  contrast  administration  or  displayed
 rim  of  mild  enhancement.  Those  with  larger  diameter
howed  early  central  and  heterogeneous  enhancement.  On
elayed  enhanced  MR  images,  enhancement  spread  cen-
rifugally  until  heterogeneous  ﬁlling  was  achieved  (Fig.  1).
istopathological  specimens  were  obtained  for  further
onﬁrmation  using  US-guided  liver  biopsy  with  a  18-gauge
2mm—penetrating  needle  on  both  non  tumoral  and  nodular
iver.
Pathological  examination  revealed  malignant  prolifera-
ion  characterised  by  an  intrasinusoidal  scaffold-like  growth
n  the  surface  of  residual  liver-cell  plates  (Fig.  2).  Tumoral
ells  showed  a  spindle  shape,  an  atypical  nuclei  and  a
peciﬁc  strong  immunoreactivity  to  vascular  endothelial
arkers  (CD31,  CD34)  (Fig.  2).  Non  tumoral  liver  tissue  was
nvolved  by  the  same  tumoral  process  with  a  peliotic  pat-
ern.
The  patient  had  no  signiﬁcant  history  of  expo-
ure  to  arsenic,  radiation,  vinyl  chloride  or  Thorotrast.
‘Metronomic’’  chemotherapy  using  cyclophosphamide  was
tarted  without  favourable  response.  The  patient  died  5
onths  after  diagnosis  with  hepatic  failure.
iscussion
robably  because  of  its  rarity,  relatively  little  has  been  writ-
en  of  enhancement  pattern  of  hepatic  angiosarcoma  HA  in
he  radiology  literature.  In  the  present  case,  MR  features
ere  atypical  from  all  of  common  liver  masses.  HA  presented
s  multiple  macronodules  disseminated  into  both  hepatic
obes.  The  tumors  were  heterogeneous  and  strongly  hyperin-
ense  on  T2-weighted  MR  images.  Most  of  lesions  presented
ith  central  and  heterogeneous  enhancement,  which  spread
rogressively  over  time.  Koyama  et  al.  already  described
his  speciﬁc,  central  and  progressive  enhancement  within
ominant  masses  of  3  patients  with  HA  who  underwent  MR
xamination  [2].
Pathologically,  HA  is  composed  of  malignant  spindle  cells
f  endothelial  cell  derivation  that  can  be  arranged  in  sinu-
oidal  or  large  cavernous  spaces,  or  form  solid  nodules  or
r Masson SAS. All rights reserved.
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Figure 1. Magnetic resonance enhancement pattern of hepatic angiosarcoma. On T2-weighted images (a), the lesions showed heteroge-
neous high intensity with focal areas of high intensity interspersed with septum-like regions of low intensity. Dynamic contrast-enhanced
images (arterial: b; portal: c; delayed 2 minutes: d and 5 minutes: e) demonstrate a slow and progressive enhancement over time, until
heterogeneous ﬁlling is obtained. On portal phase, globular and in shape enhancement is predominantly located in the central part of the
lesions. Interestingly, the most hyperintense lesions on T2-weighted images exhibited earlier and faster contrast ﬁlling than others.
Figure 2. Histopathological examination of liver biopsy sample of hepatic angiosarcoma. Residual liver plates were surrounded by numer-
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[us intrasinusoidal atypical cells (× 40 hematein-eosin saffron) (A);
peciﬁc of angiosarcoma (× 40 immunohistochemistry CD31) (B).
asses  [5].  The  irregular  and  progressive  enhancement  pat-
ern  within  dominant  masses  might  be  related  to  the  gradual
low  ﬁlling  of  high  volume  vascular  spaces.
Prior  sporadic  case  reports  have  suggested  that  HA  might
xhibit  a  progressive  centripetal  enhancement  similar  to
hat  of  cavernous  hemangioma.  In  our  patient,  none  of
he  masses  showed  MR  ﬁndings  that  were  consistent  with
emangiomas  as  they  displayed  heterogeneous  hypersig-
al  intensity  on  T2-weighted  MR  images  and  heterogeneous
entrifugal  ﬁll-in  pattern  with  the  intensity  of  enhancing
reas  different  to  that  of  the  aorta  and  blood  pool.  Other
ecent  reports  have  demonstrated  that  enhancement  pat-
ern  of  HA  should  not  be  confused  with  those  of  cavernous
emangioma.  Peterson  et  al.  described  in  6  patients  with
A  varied  enhancement  patterns  on  multiphasic  contrast-
nhanced  helical  CT  [4].  None  of  them  showed  features  of
eripheral  nodular  enhancement  isoattenuating  to  vessels
uring  the  arterial  and  portal  phases  which  could  simulate
epatic  hemangioma.  However,  some  hemangiomas  may  not
how  typical  features  on  dynamic  contrast-enhanced  CT  and
RI.  Centrifugal  enhancement  pattern  of  hemangiomas  has
[ atypical cells expressed vascular markers like CD31, CD34 that are
een  rarely  described  [6,7]. Moreover,  giant  hemangiomas
ay  show  a  heterogeneous  hyperintensity  on  T2-weighted
mages,  and  for  giant  hemangiomas  (greater  than  10  cm),
 central  or  an  irregular  ﬂame-shaped  pattern  of  enhance-
ent  [8,9]. However,  the  multiplicity  and  heterogeneity
f  lesions  in  HA,  the  patient  history  together  with  clinical
xamination  and  liver  function  tests  should  permit  distinc-
ion.
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